Edition:
United Kingdom

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

3.54USD
21 Sep 2018
Change (% chg)

$-0.11 (-3.01%)
Prev Close
$3.65
Open
$3.68
Day's High
$3.70
Day's Low
$3.50
Volume
2,861
Avg. Vol
22,977
52-wk High
$7.27
52-wk Low
$2.97

Chart for

About

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The... (more)

Overall

Beta: 0.45
Market Cap(Mil.): $131.10
Shares Outstanding(Mil.): 18.65
Dividend: --
Yield (%): --

Financials

  NVLN.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -4.87 -- --
ROI: -38.22 1.79 14.61
ROE: -93.63 3.28 16.33

BRIEF-Novelion Therapeutics Reports Quarterly Net Loss Per Share Of $1.76

* NOVELION THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

10 May 2018

Competitors

  Price Chg
Takeda Pharmaceutical Co Ltd (4502.T) ¥4,713 0.00
Pfizer Inc. (PFE.N) $44.06 +0.31
Novartis AG (NOVN.S) CHF81.88 -0.06
Merck & Co., Inc. (MRK.N) $71.10 +0.32
Roche Holding Ltd. (ROG.S) CHF235.15 +0.10
Roche Holding Ltd. (RO.S) CHF235.40 -1.20
Bayer AG (BAYGn.DE) €76.52 +0.70
Bayer AG (BAYE.F) -- --
AstraZeneca plc (AZN.L) 5,670.00 +98.00
Allergan, Inc. (AGN.N) $191.31 -1.20

Earnings vs. Estimates